|
|
DAY 1: Monday - April 23rd |
|
I |
Pharmaceutical Formulation Workshop on Tablet Dosage Forms
(Conference Room: El Coqui) - limited to 25 participants.
Abstract: This course will allow participants to develop a complete understanding of how a tablet formulation and process is rationalized. The seminar explores all areas of solid dose formulation covering theory/design, raw materials, formulation/process development, production and coating.
Presented by Emerson Resources
Workshop Leaders: Mr. Stephen Levine and Mr. Aaron Barkley (See Outline and Speakers' Resumes)
|
| II |
Overview and Implementation of Selected IPEC Guides
(Conference Room: La Luna) - limited to 25 participants.
Abstract: The International Pharmaceutical Council (IPEC) Americas has published numerous guides for the excipients industry since their inception and several others are currently in the process of being drafted. In this workshop IPEC member company representatives will present an overview of several selected IPEC Guides and discuss the practical application of these Guides in the supply of excipients. Previously only available through the IPEC Webinar series, these individual sessions will now be combined into a valuable one day, in-person workshop.
Presented By IPEC: The industry association that develops, implements, and promotes global use of appropriate quality, safety, and functionality standards for pharmaceutical excipients and excipient delivery systems.
Workshop Leaders: Dale Carter - JM Huber, David Schoneker - Colorcon, Linda Herzog - Asahi Kasei America, David Klug - sanofi-aventis, Alexa Smith - Colorcon, Ann Van Meter - DowWolff Cellulosics. (See Outline and Speakers' Resumes)
|
III |
IPEC QbD Workshop on Excipient Variability: Design & Lifecycle Implications
(Conference Room: El Caribe) limited to 25 participants.
Abstract: This workshop will provide an update to participants on recent IPEC Americas activities related to various Quality by Design initiatives. The program will include many of the presentations that IPEC Americas recently provided to over 100 key people from FDA representing many offices at the agency including New Drugs, Generic Drugs, Compliance and Pharmaceutical Sciences. These presentations will cover the following areas:
- Introduction to IPEC and IPEC Guidelines
- What we don’t know about what we don’t know?
- Types and Sources of Excipient Variability
- Performance related properties (compositional and physical)
- Limitations of possible controls in chemical plants
- Communication between maker and user
- Proper design space expectations for excipients
- Misunderstandings of what types of samples will be available for experimentation
- Integration of excipients into product DOE & design space development
- Advanced concepts for future improvements
The workshop will also cover a number of activities of the IPEC Americas QbD/Product Development Committee related to various guidelines which are being developed and interactions that IPEC Americas is having with NIPTE and PQRI on excipient variability and QbD. USP will also present information on their efforts related to General Chapter <1059> on Excipient Performance and how that chapter can be useful to assess excipient properties that may impact their performance in drug products. There will be a Panel Discussion where participants will be encouraged to ask questions related to excipient variability and it's impact on QbD.
Workshop Leader: David Schoneker (Colorcon - IPEC) & Guest Speaker: Catherine Sheehan (USP) (See Outline and Speakers' Resumes)
|
|
IV |
Excipient Supplier Auditing & Qualification
(Conference Room: El Morro) limited to 25 participants.
Abstract: The qualification of ingredient suppliers is critical to accepting incoming components through their Certificate of Analysis and to assuring the security of the excipient supply chain. While pharmaceutical companies in the past have used questionnaires to assess conformance to GMP by the excipient supplier, recent reports of sub-standard excipient demonstrate the necessity of site audits. This workshop provides suggestion on the assessment of an excipient manufacturer in the 6 hours typically allotted. The workshop also describes alternative methods of such assessment that have been received favorably by the FDA. Finally, the workshop will integrate the supplier assessment into a comprehensive incoming ingredient inspection program..
Presented by International Pharmaceutical Excipients Auditing, Inc., the industry leader in excipient Good Manufacturing Practice auditing and accreditation services.
Workshop Leader: Irwin Silverstein. (See Outline and Speakers' Resumes)
|
| |
| Workshop I
Pharmaceutical Formulation Workshop on Tablet Dosage Forms
Workshop Outline:
- Introductions
- Instructors & Emerson Inc.
- Goals
- Expectations
2. Statistics Review
- Variables
- Population
- Central tendency
- Dispersion
- Distribution
3. Raw Materials Characterization
- Physical
- Chemical
- Functional
- Classification
- Review common Excipients
4. Formulation Development
- Variable relationships
- The hypothesis
- An initial theoretical formulation
- Experimental design
5. Process Development
- Review conventional tabletting processes
- Pre-blending operations
- Granulation
- Blending
- Tabletting
- Mix time studies
- Formula & process optimization using compaction profiles
- Statistical process control
- In process specification rationalization
- Process capability
6. Tablet Coating Dynamics
- The suspension formulation
- Liquid delivery
- Process conditions
- Tablet dynamics during processing
7. Wrap up
 |
Mr. Stephen Levine
Emerson Resources Inc. |
Stephen Levine currently serves as Group Leader, Scientific Affairs, where he leads a team of formulation scientists and technicians in all aspects of their day to day activities. Stephen has worked in the pharmaceutical and chemical industries over the past 16 years in the areas of quality control, specialty coating applications, solid and liquid dose development, litigation support, clinical supplies manufacturing, new product development, process optimization, and consulting. He works with technically challenging formulations, including poorly soluble compounds, novel dosage forms, experimentally designed scale up, technical transfer problem solving, and as a troubleshooting consultant working to facilitate excellence in manufacturing. Stephen continues to lead development strategy of alternate polymer and new coating systems for taste masking, sustained release, and enteric applications. Stephen has extensive experience with CMC Project Management, designing and presenting technical training programs (internal and external), producing technical publications, and Business Development activities. Prior to his current position, Stephen served as a Formulation Scientist during which time he gained experience in a wide array of pre-formulation, granulation, tabletting, extrusion/spheronization, encapsulation, multi-particulate and API coatings, chewables, ODT tablets, and controlled release (tablet matrix and coatings), with specific expertise in taste masking, organic solvent coating, latex and pseudo-latex systems, hard capsule and softgel coatings, drug layering, and sugar coating, and cGMP documentation and clinical supplies manufacturing. Stephen has been a speaker for the AAPS, Excipientfest, and Interphex. He has had numerous technical publications and posters released in North America and Europe. Stephen holds a Bachelor of Science degree in Applied Human Anatomy and Physiology from Boston University’s Sargent College of Allied Health Professions. He also has a Master of Divinity degree from Westminster Theological Seminary.
|
|
|
 |
Mr. Aaron Barkley
Emerson Resources Inc. |
Aaron Barkley holds a Bachelor of Science degree in Biology from Waynesburg College, and has been actively involved in the pharmaceutical industry for 12 years playing critical roles in the function and growth of two product development laboratories. His latest responsibilities include business and strategy development for all aspects of Emerson Resources’ business.
Aaron has been with Emerson Resources, Inc. since its inception in 2000. Prior to his employment with Emerson, Aaron was employed by Monsanto Pharmaceutical Ingredients, and was responsible for new product development and generation of intellectual property for patents related to novel solid dose delivery systems and value-added ingredients.
With Emerson Resources, Aaron has held positions including Formulation Scientist, Senior Formulation Scientist, R&D Group Leader, Contract Services Manager, and Business and Strategy Development. He has been involved in all phases of solid dose development and is experienced with a wide variety of equipment and manufacturing techniques for the production of instant and controlled release dosage forms. His work has led to the development and marketing of several novel delivery systems in the pharmaceutical, nutraceutical and food industries. Aaron has worked in all phases of product development, technical transfer, scale-up and manufacturing, and has gained valuable experience with process optimization and introduction of new and existing production technologies and practices. Aaron was responsible for the design, construction and validation of an 8000 ft2 contract manufacturing facility as well as the implementation of business and operational systems to establish ongoing contract manufacturing.
Aaron is a member of The American Association of Pharmaceutical Scientists, New Jersey Pharmaceutical Alliance of Science and Technology and the Philadelphia Pharmaceutical Forum.
|
|
|
|
Back to Workshop Abstract |
|
| |
| Workshop II
Overview and Implementation of Selected IPEC Guides
Workshop Outline:
- Good Manufacturing Practices (GMP) Global Regulations - How they are applied to excipients and GMP for excipients. Understand and Review various global guidelines, IPEC GMP, ICHQ7, WHO GMPs & GDPs ANSI and EXCiPACT highlights.
- Significant Change - How to understand and evaluate changes involving the manufacture of pharmaceutical excipients and when reporting is needed.
- Excipient Pedigree - Why and how an understanding of the supply chain history of excipients is critical to the safety of drug products.
- Excipient Auditing - How IPEC Guidance Documents and the Excipient Information Package (EIP) Relate to the Supplier Audit Process.
- Quality Agreements - Defining Quality Agreements, General Provisions, and Key Quality Elements.
- Validation - Learn about IPEC's needed validation guideline on manufacturing processes, analytic methods and cleaning.
 |
Alexa Smith
Colorcon - IPEC |
Alexa Smith is the Global Regulatory Services Manager for Colorcon. She has been with Colorcon since June of 1997. In her current role, Alexa is primarily responsible supporting customer’s regulatory needs related to their use of Colorcon products. Alexa is also active in IPEC’s Excipient Qualification Working Group and was the Chair of their sub-committee working on Standardized Supplier Questionnaire Development. Currently, she is Co-Chair of their Quality Agreement Template sub-committee. She was recently selected to participate in USP’s Compendial Process Improvement Project Team, representing IPEC. In 2005, she was appointed as President of the Philadelphia Chapter of the Regulatory Affairs Professional Society (RAPS). Alexa is also active in the Regulatory Affairs Committee of the Council for Responsible Nutrition. She further holds a position as Adjunct Assistant Professor at Temple University. Alexa holds a M.S. in Quality Assurance and Regulatory Affairs from Temple University, a B.S. in Animal Sciences from Virginia Polytechnic Institute and State University and is Regulatory Affairs Certified (RAC) by the Regulatory Affairs Professional Society.
|
|
|
 |
Dale Carter
JM Huber- IPEC |
Dale Carter is the Global Director of Quality for the JM Huber Engineer Materials Silica Business Unit. He is responsible for product quality and compliance with IPEC/PQG GMPs for the manufacturing of Silica products at facilities in Tennessee, Maryland, India, Finland, and China. He represents JM Huber as a member of the International Pharmaceutical Excipient Council of the Americas where he is currently Chair. Dale received an MS in Chemistry from North Carolina State University and a BS in Chemistry from Davidson College. He is an ASQ Certified Quality Auditor. Prior to joining JM Huber Dale worked for Pfizer, The Coca-Cola Company, and Archer Daniels Midland Company.
|
|
|
|
|
 |
Dave Schoneker
Colorcon |
David R. Schoneker is the Director of Global Regulatory Affairs at Colorcon. His responsibilities include global coordination of Colorcon’s worldwide regulatory activities and raw material assessments. He received his B.S. degree from Ursinus College and M.S. in Chemistry from Villanova University. His previous position at Colorcon was Director of Quality Assurance and Quality Control. He has been at Colorcon since 1977. Mr. Schoneker has been active in many professional organizations such as AAPS, PQRI, RAPS, ASQ, ACS, AOAC and the Delaware Valley Chromatography Forum. He also is involved with a number of trade organizations such as the International Pharmaceutical Excipients Council (IPEC), the International Association of Color Manufacturers (IACM), the Council for Responsible Nutrition (CRN) and the Institute of Food Technologists (IFT). Mr. Schoneker is the past Chairman of IPEC Americas (2007-2008) where he is actively involved with the development of Excipient GMP and Qualification related guidelines to improve Global Supply Chain Security. Mr. Schoneker is a frequent speaker at ExcipientFest.
|
|
|
 |
Linda Herzog
Asahi Kasei |
Linda Herzog is Director, Technical Sales & Marketing for Pharmaceutical and Food Ingredients at Asahi Kasei America, Inc. She has worked in the excipients and pharmaceutical industry for 10 years, formerly as Sales Director and General Manager for an excipients distributor. Linda has been an enthusiastic supporter and advocate of excipient good manufacturing and distribution practices and was a member of the group who authored IPEC’s Excipient Pedigree Position Paper in 2007. She gives talks in the US and Europe on excipient supply chain integrity and security, especially as they relate to distributors and other non-manufacturing suppliers. Linda serves on the IPEC excipients Good Manufacturing Practices committee and the USP Expert Panel for General Chapter <1197> Good Distribution Practices for Bulk Pharmaceutical Excipients. She holds a BA in Chemistry from the College of the Holy Cross and an MBA in Marketing and Finance from the University of Connecticut.
|
|
|
|
|
 |
David Klug
sanofi-aventis |
Mr. David Klug – Senior Manager, Supplier Audit – sanofi-aventis: David Klug has been with sanofi-a ventis since 1995. In his current role, David is responsible for GMP compliance audits of suppliers of materials used in U.S. marketed products. He currently serves on the IPEC Americas' Executive Committee and as Chair for the Excipient Qualification committee, which is completing a revision to the IPEC Certificate of Analysis Guide. David has participated in development of numerous IPEC guides, including Qualification of Excipients for Use in Pharmaceuticals; 2008, IPEC Excipient Information Package (EIP): Template and User Guide, 2009 and The IPEC Quality Agreement Guide and Template, 2009. Formerly employed by Mallinckrodt, David holds an MS degree in Chemistry from the University of Missouri - Columbia. This is his first year speaking at ExcipientFest.
|
|
|
 |
Ann van Meter
DowWolff Cellulosics |
Pending.
|
|
|
|
Back to Workshop Abstract |
|
| |
| |
| Workshop III
IPEC QbD Workshop on Excipient Variability: Design & Lifecycle Implications
Workshop Outline:
- Pending
 |
Dave Schoneker
Colorcon |
David R. Schoneker is the Director of Global Regulatory Affairs at Colorcon. His responsibilities include global coordination of Colorcon’s worldwide regulatory activities and raw material assessments. He received his B.S. degree from Ursinus College and M.S. in Chemistry from Villanova University. His previous position at Colorcon was Director of Quality Assurance and Quality Control. He has been at Colorcon since 1977. Mr. Schoneker has been active in many professional organizations such as AAPS, PQRI, RAPS, ASQ, ACS, AOAC and the Delaware Valley Chromatography Forum. He also is involved with a number of trade organizations such as the International Pharmaceutical Excipients Council (IPEC), the International Association of Color Manufacturers (IACM), the Council for Responsible Nutrition (CRN) and the Institute of Food Technologists (IFT). Mr. Schoneker is the past Chairman of IPEC Americas (2007-2008) where he is actively involved with the development of Excipient GMP and Qualification related guidelines to improve Global Supply Chain Security. Mr. Schoneker is a frequent speaker at ExcipientFest.
|
|
|
 |
Catherine Sheehan
US Pharmacopeia |
Ms. Sheehan is Director of Excipients in the Documentary Standards Division, United States Pharmacopeia, Rockville, MD. In her current role, she is responsible for development and update of excipient monographs and related chapters, and participates in the Pharmacopeial Discussion Group’s compendial harmonization of excipient monographs and excipient chapters. Ms. Sheehan is active in AAPS and RAPS. She was a member on the Product Quality Research Institute, Excipient Working Group from 2006-2007 and was co-author of the group’s two published articles that appeared in Pharmaceutical Technology , “PQRI survey of Pharmaceutical Excipient testing and Control strategies used by excipient manufacturers, excipient distributors and drug product manufacturers”, and “PQRI Joint Position Paper on Pharmaceutical Excipient testing and Control strategies”. Ms. Sheehan is a graduate of University College Cork, Ireland. She holds a B.Sc. Degree from University College Cork, Ireland. She holds an M.S. Bioscience Regulatory Affairs from Johns Hopkins University, USA. This is her third time speaking at ExcipientFest.
|
|
|
|
Back to Workshop Abstract |
|
| |
| |
| Workshop IV
Excipient Supplier Auditing & Qualification
Workshop Outline:
-
Establish FDA expectation for qualification of suppliers
2. Present the prime areas of concern in auditing an excipient supplier for qualification
a. Recommend operational areas of emphasis and procedures of particular interest
b. Discuss recent findings and their importance
c. Review expectations for auditing the entire supply chain
d. Discuss various operational activities that may be performed by a “distributor” vs. broker and trader.
3. Discuss the use of COA in approval of ingredients
4. Review FDA expectations for periodic qualification of COA
5. Present a holistic approach to approval of incoming ingredients:
a. Review of COA
b. Sampling plan and identification testing
c. Review of packaging
d. Review of labeling
e. Review of tamper-evident seals
 |
Irwin Silverstein
IPEA Inc. |
Irwin Silverstein is a consultant specializing in quality assurance and regulatory compliance for pharmaceutical excipient ingredients. He also has experience in quality assurance for API, medical device and drug products. He was formerly the Corporate Director of Quality Assurance for International Specialty Products (ISP) where he spent 17 of his 22 years leading the Quality Unit responsible for excipients, API, and medical devices. He has worked for over 18 years with the International Pharmaceutical Excipients Council (IPEC) developing guidance documents for excipient GMP compliance. In addition to working as a consultant to the industry, he is the VP and Chief Operating Officer of International Pharmaceutical Excipients Auditing Inc (IPEA). He began consulting as an expert consultant hired by pharmaceutical firms under FDA Consent Decree. Recent consulting includes pharmaceutical firms where he assesses conformance to site requirements and GMP gap assessments of excipient manufacturers. As an experienced GMP auditor, with American Society for Quality (ASQ) Certified Quality Auditor (CQA) status as well as ISO 9000 Certified Lead Auditor training, he has developed IPEA auditor training programs for hourly and supervisory personnel. He is establishing IPEA as an accredited organization to issue certification to excipient GMP in conformance with ANSI requirements.
|
|
|
|
|
|
Back to Workshop Abstract |
|
| |
|